Name | UCPH-102 |
---|---|
Synonyms |
4H-1-Benzopyran-3-carbonitrile, 2-amino-5,6,7,8-tetrahydro-4-methyl-7-(1-naphthalenyl)-5-oxo-
2-Amino-4-methyl-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile UCPH-102 2-Amino-4-methyl-7-(1-naphthyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile 2-Amino-5,6,7,8-tetrahydro-4-methyl-7-(1-naphthalenyl)-5-oxo-4H-1-benzopyran-3-carbonitrile |
Description | UCPH-102 is a highly selective EAAT1 inhibitor with an IC50 of 0.43 µM. UCPH-102 exhibits a specific anti-proliferative effect on T-ALL cells. UCPH-102 also shows good blood-brain permeability, which can be used in studies of amyotrophic lateral sclerosis, Alzheimer’s disease, chronic pain and obsessive compulsive disorder[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
IC50: 0.43 µM (EAAT1)[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 610.7±55.0 °C at 760 mmHg |
Molecular Formula | C21H18N2O2 |
Molecular Weight | 330.380 |
Flash Point | 323.2±31.5 °C |
Exact Mass | 330.136841 |
LogP | 2.68 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.676 |